P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

August 2008

Features

Monitoring Asthma Control Using Claims Data and Patient-Reported Outcomes Measures

Inadequately controlled asthma can be very debilitating and costly for patients. The authors emphasize the importance of tracking symptoms, and they recommend a combined strategy in which both patient and claims data are used to ­identify poor asthma control.
Tom James, MD, and Michael Fine, MD

Case Report

Low-Dose, Off-Label Drotrecogin Alfa (Xigris) in Severe Sepsis

A patient with multiple-organ failure recovered from septic shock when a low dose of drotrecogin alfa was administered.
Shan Wang, PharmD, Kristina Dabovic, PharmD, and Ruth S. Spector, MD

Meeting Highlights

American Society of Hypertension 23rd Annual Scientific Meeting and Exposition

Antihypertensive treatments include a dual receptor antagonist (PS433540) and a combination of amlodipine plus olmesartan (Azor).
Reuben B. David

Continuing Education Credit

The Pharmacological Management of Migraine, Part 2 Preventative Therapy

Part 2 of a two-part series summarizes treatments used to prevent migraine, the most common headache complaint in clinical practice. Current prophylactic ­therapies include selected beta blockers, antidepressants, anticonvulsant agents, NSAIDs, skeletal muscle relaxants, ACE-inhibitors, antipsychotic agents, ­antihistamines, botulinum, and herbal products.
George DeMaagd, PharmD, BCPS

Departments

Editorial

The Four-Way Win

David Nash, MD, MBA, describes the concept of "total leadership" and its value in helping people become more authentic, ­integrated, and ­creative.
David B. Nash, MD, MBA

Medication Errors

The Truth about Hospital Formularies, Part 1

In part 1 of a two-part article, Matthew Grissinger, RPh, FASCP, discusses widespread misconceptions about formularies among surveyed health care professionals.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Senate May Compromise on 'Biosimilars'

Stephen Barlas discusses the possible passage of a Senate bill that would allow the FDA to approve "near copies" of biotech agents ("biosimilars").
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From dronabinol to rosi­glitazone, P&T presents the latest information about FDA approvals, new indications, recalls, and industry updates.

Drug Forecast

Combating Non-nucleoside Reverse Transcriptase Inhibitor Resistance with a Focus On Etravirine (Intelence) for HIV-1 Infection

The authors review etravirine (Intelence), a second-generation non-nucleoside reverse transcriptase inhibitor, for HIV-1 infection.
Nathaniel Eraikhuemen, PharmD, Angela M. Thornton, PharmD, Evans Branch III, PharmD, Sandrine T. Huynh, PharmD, and Candace Farley, PharmD